I picked up on the same...
Probably the most important few words wasn't worthy of the quarterly.
I did have a concerning thought that the reference to stable is; the patients after having been on MPL for 9 months+ are still stable, as in not showing any evidence of adverse effects as a result of long term use. This would be inline with the overall point of the phase 1.
Anyone care to point out how this is definitely not plausible?
Ann: MND Trial Successfully Completes 3rd Patient Cohort, page-47
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.00M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.8¢ | $199.9K | 985.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 554456 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 58399 | 3 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |